Home Recalls D-0852-2022
Class II · Moderate risk Terminated Initiated Apr 11, 2022 (4 years ago)
Pantoprazole Sodium Delayed-Release Tablets, USP, 20 mg, Rx Only, 90 tablets per bottle…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP deviations: tablets cracking
What was recalled
Pantoprazole Sodium Delayed-Release Tablets, USP, 20 mg, Rx Only, 90 tablets per bottle, Manufactured by: Torrent Pharmaceuticals Ltd., Indrad-382 721, India, Manufactured for: Torrent Pharma Inc., Levittown, PA 19057, NDC# 13668-096-90.
Recalling firm Torrent Pharma Inc
NDC code 13668-096-90
Origin PA, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0852-2022
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing Mar 26, 2026
Reason Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
Class II · Moderate risk Terminated Sep 5, 2023
Reason Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
Class II · Moderate risk Completed Apr 7, 2023
Reason CGMP Deviations; The impacted product and lot number was inadvertently placed into saleable inventory, which does not comply with approved procedures.
Class II · Moderate risk Ongoing Mar 14, 2023
Reason CGMP Deviations: Discoloration
Class II · Moderate risk Terminated Dec 27, 2022
Reason Lack of sterility assurance